Skip to main content
Log in

Predictive Factors for Rebleeding and Death in Alcoholic Cirrhotic Patients with Acute Variceal Bleeding: A Multivariate Analysis

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Bleeding from esophageal varices is a leading cause of death in alcoholic cirrhotic patients. The aim of the present single-center study was to identify risk factors predictive of variceal rebleeding and death within 6 weeks of initial treatment.

Methods

Univariate and multivariate analyses were performed on 310 prospectively documented alcoholic cirrhotic patients with acute variceal hemorrhage (AVH) who underwent 786 endoscopic variceal injection treatments between January 1984 and December 2006. All injections were administered during the first 6 weeks after the patients were treated for their first variceal bleed.

Results

Seventy-five (24.2%) patients experienced a rebleed, 38 within 5 days of the initial treatment and 37 within 6 weeks of their initial treatment. Of the 15 variables studied and included in a multivariate analysis using a logistic regression model, a bilirubin level >51 mmol/l and transfusion of >6 units of blood during the initial hospital admission were predictors of variceal rebleeding within the first 6 weeks. Seventy-seven (24.8%) patients died, 29 (9.3%) within 5 days and 48 (15.4%) between 6 and 42 days after the initial treatment. Stepwise multivariate logistic regression analysis showed that six variables were predictors of death within the first 6 weeks: encephalopathy, ascites, bilirubin level >51 mmol/l, international normalized ratio (INR) >2.3, albumin <25 g/l, and the need for balloon tube tamponade.

Conclusions

Survival was influenced by the severity of liver failure, with most deaths occurring in Child-Pugh grade C patients. Patients with AVH and encephalopathy, ascites, bilirubin levels >51 mmol/l, INR >2.3, albumin <25 g/l and who require balloon tube tamponade are at increased risk of dying within the first 6 weeks. Bilirubin levels >51 mmol/l and transfusion of >6 units of blood were predictors of variceal rebleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Krige JEJ, Shaw JM, Bornman PC (2005) The evolving role of endoscopic treatment for bleeding esophageal varices. World J Surg 29:966–973

    Article  PubMed  CAS  Google Scholar 

  2. Krige JEJ, Beningfield SJ, Shaw J (2007) Management of bleeding oesophageal varices. In: Johnson C, Taylor I (eds) Recent advances in surgery, 30th edn. Royal Society of Medicine, London, pp 105–125

    Google Scholar 

  3. Sharara AI, Rockey DC (2001) Gastroesophageal variceal hemorrhage. N Engl J Med 345:669–681

    Article  PubMed  CAS  Google Scholar 

  4. Triantos CK, Goulis J, Patch D et al (2006) An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy 38:797–807

    Article  PubMed  CAS  Google Scholar 

  5. Chalasani N, Kahi C, Francois F et al (2003) Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 98:653–659

    Article  PubMed  Google Scholar 

  6. Carbonell N, Pauwels A, Serfaty L et al (2004) Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology 40:652–659

    Article  PubMed  Google Scholar 

  7. Mihas AA, Sanyal AJ (2004) Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology 127:621–629

    Article  PubMed  Google Scholar 

  8. Henderson JM, Barnes DS, Geisinger MA (1998) Portal hypertension. Curr Probl Surg 35:379–452

    Article  PubMed  CAS  Google Scholar 

  9. Christensen E (1997) Prognostic models in chronic liver disease: validity, usefulness and future role. J Hepatol 26:1414–1424

    Article  PubMed  CAS  Google Scholar 

  10. Terblanche J, Bornman PC, Kahn D (1983) Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding: a five-year prospective controlled clinical trial. Lancet 2:1328–1332

    Article  PubMed  CAS  Google Scholar 

  11. Terblanche J, Kahn D, Bornman PC (1989) Long-term injection sclerotherapy treatment for esophageal varices: a 10 year prospective evaluation. Ann Surg 210:725–731

    Article  PubMed  CAS  Google Scholar 

  12. Bornman PC, Kahn D, Terblanche J et al (1988) Rigid versus fiberoptic endoscopic injection sclerotherapy. A prospective randomized controlled trial in patients with bleeding esophageal varices. Ann Surg 208:175–178

    Article  PubMed  CAS  Google Scholar 

  13. Kahn D, Krige JE, Terblanche J et al (1994) A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction. Ann Surg 219:34–39

    Article  PubMed  CAS  Google Scholar 

  14. Krige JE, Bornman PC, Goldberg PA et al (2000) Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients. Arch Surg 135:1315–1322

    Article  PubMed  CAS  Google Scholar 

  15. Krige JEJ, Kotze UK, Bornman PC et al (2006) Recurrence, rebleeding and survival after endoscopic injection sclerotherapy in alcoholic patients with bleeding esophageal varices. Ann Surg 244:764–770

    Article  PubMed  Google Scholar 

  16. Krige JEJ, Terblanche J (1996) Injection sclerotherapy of oesophageal varices. In: Carter D, Russell RCG, Pitt H, Bismuth H (eds) Rob and Smith’s operative surgery. Surgery of the liver, pancreas and bile ducts, 5th edn. Chapman and Hall Medical, London, pp 163–172

    Google Scholar 

  17. Krige JEJ, Bornman PC (2007) Endoscopic therapy in the management of esophageal varices: injection sclerotherapy and variceal ligation. In: Blumgart L (ed) Surgery of the liver, biliary tract and pancreas, 4th edn. Saunders Elsevier, Philadelphia, pp 1579–1593

    Google Scholar 

  18. Krige JEJ, Bornman PC (2006) Endoscopic therapy in the management of esophageal varices: injection sclerotherapy and variceal ligation. In: Fischer JE (ed) Mastery of surgery, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1367–1378

    Google Scholar 

  19. Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649

    Article  PubMed  CAS  Google Scholar 

  20. D’Amico G, De Franchis R, Cooperative Study Group (2003) Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38:599–612

    Article  PubMed  Google Scholar 

  21. Thomopoulos K, Theocharis G, Mimidis K et al (2006) Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis 38:899–904

    Article  PubMed  CAS  Google Scholar 

  22. Boix J, Lorenzo-Zúñiga V, Moreno de Vega V et al (2007) Sclerotherapy and esophageal variceal bleeding: time to forget it, or not? Endoscopy 39:478

    Article  PubMed  CAS  Google Scholar 

  23. Ben-Ari Z, Cardin F, McCormick AP et al (1999) A predictive model for failure to control bleeding during acute variceal haemorrhage. J Hepatol 31:443–450

    Article  PubMed  CAS  Google Scholar 

  24. Siringo S, McCormick PA, Mistry P et al (1991) Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc 37:51–55

    Article  PubMed  CAS  Google Scholar 

  25. Zhao C, Chen SB, Zhou JP et al (2002) Prognosis of hepatic cirrhosis patients with esophageal or gastric variceal hemorrhage: multivariate analysis. Hepato-Biliary Pancreat Dis Int 1:416–419

    Google Scholar 

  26. Jalan R, Hayes PC (2000) UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology. Gut 46(Suppl 3–4):III1–III15

    PubMed  Google Scholar 

  27. Poynard T, Lebrec D, Hillon P et al (1987) Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding. Hepatology 7:447–451

    Article  PubMed  CAS  Google Scholar 

  28. Sanders DS, Carter MJ, Goodchap RJ et al (2002) Prospective validation of the Rockall risk scoring system for upper GI hemorrhage in subgroups of patients with varices and peptic ulcers. Am J Gastroenterol 97:630–635

    Article  PubMed  CAS  Google Scholar 

  29. Bosch J, Berzigotti A, Garcia-Pagan JC et al (2008) The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 48(Suppl 1):S68–S92

    Article  PubMed  CAS  Google Scholar 

  30. Bhasin DK, Siyad I (2004) Variceal bleeding and portal hypertension: new lights on old horizon. Endoscopy 36:120–129

    Article  PubMed  CAS  Google Scholar 

  31. Goulis J, Armonis A, Patch D et al (1998) Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 27:1207–1212

    Article  PubMed  CAS  Google Scholar 

  32. Bernard B, Grangé JD, Khac EN et al (1999) Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29:1655–1661

    Article  PubMed  CAS  Google Scholar 

  33. Avgerinos A, Armonis A, Stefanidis G et al (2004) Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis. Hepatology 39:1623–1630

    Article  PubMed  Google Scholar 

  34. Monescillo A, Martínez-Lagares F, Ruiz-del-Arbol L et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40:793–801

    PubMed  Google Scholar 

  35. Moitinho E, Escorsell A, Bandi JC et al (1999) Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 117:626–631

    Article  PubMed  CAS  Google Scholar 

  36. de Franchis R (2005) Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 43:167–176

    Article  PubMed  Google Scholar 

  37. Bosch J, Abraldes JG, Groszmann R (2003) Current management of portal hypertension. Hepatology 38:S54–S68

    Google Scholar 

  38. Le Moine O, Adler M, Bourgeois N et al (1992) Factors related to early mortality in cirrhotic patients bleeding from varices and treated by urgent sclerotherapy. Gut 33:1381–1385

    Article  PubMed  Google Scholar 

  39. Graham DY, Smith JL (1981) The course of patients after variceal hemorrhage. Gastroenterology 80:800–809

    PubMed  CAS  Google Scholar 

  40. Graffeo M, Buffoli F, Lanzani G et al (1994) Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics. Am J Gastroenterol 89:1815–1822

    PubMed  CAS  Google Scholar 

  41. Prindiville T, Miller M, Trudeau W (1987) Prognostic indicators in acute variceal hemorrhage after treatment by sclerotherapy. Am J Gastroenterol 82:655–659

    PubMed  CAS  Google Scholar 

  42. Yang MT, Chen HS, Lee HC et al (2007) Risk factors and survival of early bleeding after esophageal variceal ligation. Hepatogastroenterology 54:1705–1709

    PubMed  Google Scholar 

  43. Amitrano L, Guardascione MA, Bennato R et al (2005) MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices. J Hepatol 42:820–825

    Article  PubMed  Google Scholar 

  44. Cárdenas A, Ginès P, Uriz J et al (2001) Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 34:671–676

    Article  PubMed  Google Scholar 

  45. Garden OJ, Motyl H, Gilmour WH et al (1985) Prediction of outcome following acute variceal haemorrhage. Br J Surg 72:91–95

    Article  PubMed  CAS  Google Scholar 

  46. Lata J, Husová L, Juránková J et al (2006) Factors participating in the development and mortality of variceal bleeding in portal hypertension—possible effects of the kidney damage and malnutrition. Hepatogastroenterology 53:420–425

    PubMed  Google Scholar 

  47. Gatta A, Merkel C, Amodio P et al (1994) Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study. Am J Gastroenterol 89:1528–1536

    PubMed  CAS  Google Scholar 

  48. Hori S, Takaki A, Okada H et al (2006) Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients. J Gastroenterol Hepatol 21:1704–1709

    Article  PubMed  Google Scholar 

  49. Srikureja W, Kyulo NL, Runyon BA et al (2005) MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis. J Hepatol 42:700–706

    Article  PubMed  Google Scholar 

  50. Lo GH, Chen WC, Chen MH et al (2004) The characteristics and the prognosis for patients presenting with actively bleeding esophageal varices at endoscopy. Gastrointest Endosc 60:714–720

    Article  PubMed  Google Scholar 

  51. D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217–231

    Article  PubMed  Google Scholar 

  52. Garcia-Tsao G, Bosch J, Groszmann RJ (2008) Portal hypertension and variceal bleeding—unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single-topic conference. Hepatology 47:1764–1772

    Article  PubMed  Google Scholar 

  53. Atkinson RJ, Hurlstone DP (2008) Usefulness of prognostic indices in upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 22:233–242

    Article  PubMed  Google Scholar 

  54. Angermayr B, Cejna M, Karnel F et al (2003) Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 52:879–885

    Article  PubMed  CAS  Google Scholar 

  55. Cholongitas E, Papatheodoridis GV, Vangeli M et al (2005) Systematic review: the model for end-stage liver disease–should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 22:1079–1089

    Article  PubMed  CAS  Google Scholar 

  56. Bambha K, Kim WR, Pedersen R et al (2008) Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 57:814–820

    Article  PubMed  CAS  Google Scholar 

  57. Huo TI, Lee SD, Lin HC (2008) Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 28:606–613

    Article  PubMed  Google Scholar 

  58. Thalheimer U, Triantos CK, Samonakis DN et al (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54:556–563

    Article  PubMed  CAS  Google Scholar 

  59. Thabut D, Bernard-Chaber TB (2007) Management of acute bleeding from portal hypertension. Best Pract Res Clin Gastroenterol 21:19–29

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jake E. J. Krige.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krige, J.E.J., Kotze, U.K., Distiller, G. et al. Predictive Factors for Rebleeding and Death in Alcoholic Cirrhotic Patients with Acute Variceal Bleeding: A Multivariate Analysis. World J Surg 33, 2127–2135 (2009). https://doi.org/10.1007/s00268-009-0172-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-009-0172-6

Keywords

Navigation